Supplementary Tables from Proteasome Inhibition Overcomes ALK-TKI Resistance in <i>ALK</i>-Rearranged/<i>TP53</i>-Mutant NSCLC via Noxa Expression

Supplementary Table 1. Predicted biological function of TP53 mutations detected in ALK-rearranged non-small cell lung cancer patients Supplementary Table 2. Baseline charcteristics of ALK-rearranged non-small cell lung cancer patients with and without TP53 mutations Supplementary Table 3. Predicted biological function of ATM mutations detected in ALK-rearranged non-small cell lung cancer patients